HIVE Digital Technologies Ltd (HIVE)
Official siteFINANCIAL SERVICES • CAPITAL MARKETS • NASDAQ
Market Cap: $434.70M
Last updated: Nov 17, 2026 at 11:06 AM ET
HIVE Digital Technologies Ltd (HIVE) Stock Forecast
Analysts expect HIVE Digital Technologies (HIVE) to earn -$0.43 per share in the fiscal year ending Mar 31, 2027, on revenue of $350.88M. Of 9 analysts, 8 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Mar 31, 2028, the EPS consensus is -$0.21.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 9 ratings average 2.11, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 89% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 8 | 88.9% |
| Hold | 1 | 11.1% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 9
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 41.9%.
- Fiscal year ending Mar 31, 2027
- -$0.43
- EPS consensus, revenue $350.88M
- Fiscal year ending Mar 31, 2028
- -$0.21
- EPS consensus, revenue $497.92M
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Mar 31, 2027 | -$0.43 | -$0.43 to -$0.43 | 1 | $350.88M | $322.51M to $380.57M | 7 |
| Mar 31, 2028 | -$0.21 | -$0.21 to -$0.21 | 1 | $497.92M | $394.84M to $632.40M | 8 |
Quarterly Estimates
The EPS consensus falls from -$0.05 for the quarter ending Dec 31, 2026 to -$0.13 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.05 | -$0.05 to -$0.05 | 1 | $86.97M | $79.43M to $94.90M | 4 |
| Mar 31, 2027 | -$0.13 | -$0.19 to -$0.06 | 8 | $101.90M | $69.34M to $127.76M | 7 |
Estimate Revisions
No EPS estimate for the 3 periods below was revised in the last 30 days.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Mar 31, 2027 | 0 | 0 |
| Fiscal year ending Mar 31, 2028 | 0 | 0 |
| Quarter ending Dec 31, 2026 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Mar 31, 2027 has worsened from -$0.17.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Mar 31, 2027 | -$0.43 | -$0.34 | N/A | -$0.43 | -$0.17 | N/A |
| Fiscal year ending Mar 31, 2028 | -$0.21 | -$0.09 | N/A | -$0.21 | $0.02 | N/A |
| Quarter ending Dec 31, 2026 | -$0.05 | N/A | N/A | -$0.10 | -$0.10 | N/A |
Frequently Asked Questions About HIVE
What is the HIVE stock forecast?
Consensus analyst estimates put HIVE Digital Technologies's EPS at -$0.43 for the fiscal year ending Mar 31, 2027, on revenue of $350.88M. The consensus rating from 9 analysts is Buy.
How do analysts rate HIVE stock?
Of 9 analysts covering HIVE Digital Technologies, 0 rate it Strong Buy, 8 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from HIVE next year?
For the fiscal year ending Mar 31, 2027, the consensus EPS estimate is -$0.43, with estimates from -$0.43 to -$0.43 from 1 analyst. For the fiscal year ending Mar 31, 2028, the consensus EPS estimate is -$0.21, with estimates from -$0.21 to -$0.21 from 1 analyst.
What revenue do analysts expect from HIVE Digital Technologies next year?
For the fiscal year ending Mar 31, 2027, the consensus revenue estimate is $350.88M, with estimates from $322.51M to $380.57M. For the fiscal year ending Mar 31, 2028, the consensus revenue estimate is $497.92M, with estimates from $394.84M to $632.40M.
How many analysts cover HIVE?
9 analysts rate HIVE Digital Technologies stock, and 1 analyst estimates its EPS for the fiscal year ending Mar 31, 2027.
HIVE pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors